Ticker ATHE – Alterity Therapeutics – sales, description, marketcap – Tickerday.com

ATHE

Alterity Therapeutics

Index: NASDAQ; Sector: Healthcare; Industry: Biotechnology & Drugs;

Marketcap: 37.08M; Volume: 19.14K; AvgVol 3m: 2.81M; Beta: 1.44;

Cost estimate:

P/E: ; EPS: -0.64; EPS growth quarter/prev quarter: 2.90%;

EPS growth this year: 25.00%; EPS growth past 5 years: -5.10%;

EPS ttm: -0.65;

P/S: ; P/B: 6.26; P/Cashflow: ; P/FCF: ;

Sales: 1.10K; Sales growth quarter/prev quarter: ; Sales growth past 5 years: ;

Profitability:

Gross Margin: ; Profit Margin: ; Operating Margin: ;

ROA – return on assets: -92.10%; ROE – return on equity: -117.50%; LT Debt/Equity: 0.00; Total Debt/Equity: 0.00;

Dividend: ; Dividend Yield (%): ;

Insider Ownership: 18.70%; Insider Transactions:0.00%;

Institutional Ownership: 3.00%; Institutional Transactions: 64.10%;

Data update: 07.10.2020.

Leave a comment

Your email address will not be published. Required fields are marked *